McGraw Hill, Inc.
MHMcGraw Hill, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is between stages. Underneath, the last four quarters read deteriorating. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
McGraw Hill, Inc. trades at $11.6, between stages. That is −12.6% against its own 200-day average. It sits at 26% of a 52-week range of $9 to $18. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (26 weeks and counting).
Today the stock is between stages. At $11.6 it trades −12.6% versus its 200-day average and sits at 26% of its 52-week range ($9–$18).
Against the market, two honest reads. Cumulative: over the last 1.0 years the stock moved −31% while the S&P 500 moved +21% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (26 weeks and counting; last ahead the week of 2026-02-06) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
McGraw Hill, Inc. trades at 60.8× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 60.8× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
McGraw Hill, Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 2 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +0.0% | +2.5% | — | — |
| Stock price | −24.5% | — | — | — |
4-Factor Sector Score
28.3/100 — rank 17 of 20 in Education & Training Services · 58% evidence confidence
McGraw Hill, Inc. scores 28.3 out of 100 against the 20 companies it is compared with in Education & Training Services, ranking 17. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 10.5 + 5 + 8.7 + 4.1 = 28.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
McGraw Hill, Inc. reported $0.5 B of revenue in the Mar 26 quarter, −2.1% year on year. Over 4 years it has compounded at 4.1% a year. The last full year, FY26, came in at $2.1 B. The last four reported quarters add to $2.1 B.
FY26 revenue came in at $2.1 B (+0.0% on the year), capping 4 years at 4.1% compound. The latest quarter (Mar 26) printed $0.5 B, −2.1% year on year.
Pace check: the last four quarters averaged +0.3% growth against the decade's 4.1% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +0.0% over the last 4 quarters against +3.5%/yr over the last 8 — rolling over.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
McGraw Hill, Inc.'s operating margin is −2.2% in the Mar 26 quarter, −8.6 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −19.6% to 14.8%. The current quarter sits inside that band.
The latest quarter's operating margin is −2.2%, −8.6 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −19.6%–14.8%.
🚨 Why the margin moved: operating margin went −8.6 pp year on year while gross margin went +1.8 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
McGraw Hill, Inc. posted a net loss of $0.1 B in the Mar 26 quarter. Full-year FY26 profit was $0.0 B. That loss is 10.9% of the quarter's revenue. The same quarter a year earlier lost $0.2 B. 8 of the last 12 reported quarters were loss-making.
Mar 26 profit was $−0.1 B, null year on year. On the full year, FY26 printed $0.0 B (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
McGraw Hill, Inc.'s cash-flow history is too thin to judge how much reported profit converts into cash. In FY26 that was $0.3 B of operating cash against $0.0 B of profit. After $0.1 B of capital spending, $0.3 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY26: operating cash of $0.3 B against reported profit of $0.0 B, leaving free cash of $0.3 B after $0.1 B of capital spending.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
McGraw Hill, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY26 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
McGraw Hill, Inc. earns a ROE of 6% in FY26. That is up from a trough of −71% in FY23. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 1.9% net margin on 0.38× asset turns.
FY26 ROE is 6%, recovered from a FY23 trough of −71% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 1.9% net margin × 0.38× asset turns × 7.52× balance-sheet leverage ≈ 5.4% on equity. Margin does its share; leverage is a meaningful part of the equation.
Dividend
McGraw Hill, Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
McGraw Hill, Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
McGraw Hill, Inc. carries total debt of $2.6 B against shareholder equity of $0.7 B as of Mar 26, a debt-to-equity of 3.62. On the annual view that ratio went from 3.88 in FY22 to 3.62 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of $2.6 B against shareholder equity of $0.7 B — a debt-to-equity of 3.62. On the annual view, debt-to-equity went from 3.88 (FY22) to 3.62 (FY26). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
8.5% of McGraw Hill, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 1.8 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 8.5% of the float is sold short, and at typical trading volumes it would take about 1.8 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
McGraw Hill, Inc.: the Z-score reads 0.54. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
🚨 Why it matters: a Z-score of 0.54 is inside the distress zone — the balance sheet is a real risk, not a detail.
The safety line in one sentence: the Z-score reads 0.54.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Lincoln Educational Services CorporationLINC | 59.1/100Mixed-positive evidence75% evidence | FADING | 24.9/35 Revenue 19.8% · PAT 91.7% · OPM change 1.6 pp 83% evidence | 7.7/25 ROCE 1.7% · OPM 4.5% 76% evidence | 9.5/20 P/E 57.3× · PEG 1.28 65% evidence | 17.0/20 RS sector 15.4% · RS bench 21.1% · 1Y 81.7%8 of 12 weeks ahead 70% evidence |
| Exact sum: 24.9 + 7.7 + 9.5 + 17 = 59.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2American Public Education, Inc.APEI | 57.6/100Mixed-positive evidence65% evidence | ASLEEP | 22.6/35 Revenue 3.8% · PAT 64% · OPM change 5 pp 83% evidence | 10.5/25 ROCE 4.6% · OPM 12.4% 76% evidence | 9.3/20 P/E 30.1× · PEG — 15% evidence | 15.2/20 RS sector 2.6% · RS bench 8% · 1Y 79.1%2 of 12 weeks ahead 70% evidence |
| Exact sum: 22.6 + 10.5 + 9.3 + 15.2 = 57.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Grand Canyon Education, Inc.LOPE | 55.8/100Thin evidence · provisional58% evidence | BASING | 22.1/35 Revenue — · PAT — · OPM change 0.5 pp 45% evidence | 21.5/25 ROCE 32% · OPM 30.9% 76% evidence | 9.8/20 P/E 17.3× · PEG — 15% evidence | 2.4/20 RS sector -25.2% · RS bench -21.3% · 1Y -23.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 21.5 + 9.8 + 2.4 = 55.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Perdoceo Education CorporationPRDO | 54.3/100Mixed-positive evidence81% evidence | ASLEEP | 22.5/35 Revenue 17.9% · PAT 12.6% · OPM change 4.2 pp 83% evidence | 15.0/25 ROCE 5.6% · OPM 28.5% 76% evidence | 14.1/20 P/E 14.3× · PEG 0.92 65% evidence | 2.7/20 RS sector -15% · RS bench -10.6% · 1Y 5.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 15 + 14.1 + 2.7 = 54.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Franklin Covey Co.FC | 51.1/100Mixed-positive evidence71% evidence | BASING | 21.5/35 Revenue -6.1% · PAT -81.8% · OPM change 9.5 pp 71% evidence | 11.3/25 ROCE 5.8% · OPM 6.2% 76% evidence | 7.0/20 P/E 139.5× · PEG 1.77 65% evidence | 11.3/20 RS sector -3% · RS bench 1.9% · 1Y 14.6%6 of 12 weeks ahead 70% evidence |
| Exact sum: 21.5 + 11.3 + 7 + 11.3 = 51.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6TAL Education GroupTAL | 51.0/100Thin evidence · provisional58% evidence | TURNING | 21.5/35 Revenue — · PAT — · OPM change 11.6 pp 45% evidence | 8.6/25 ROCE 3.2% · OPM 9% 76% evidence | 11.5/20 P/E 6× · PEG — 15% evidence | 9.4/20 RS sector -7.4% · RS bench -2.2% · 1Y 4.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 8.6 + 11.5 + 9.4 = 51 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Universal Technical Institute, Inc.UTI | 50.2/100Mixed-positive evidence81% evidence | BREAKING OUT | 9.4/35 Revenue 11.1% · PAT -24.6% · OPM change -7.9 pp 83% evidence | 8.2/25 ROCE 0.1% · OPM 0.2% 76% evidence | 14.1/20 P/E 46.9× · PEG 0.53 65% evidence | 18.5/20 RS sector 10.1% · RS bench 15.5% · 1Y 57.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 9.4 + 8.2 + 14.1 + 18.5 = 50.2 · Decision use: Price leads the evidence: RS versus the benchmark is 15.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 8Legacy Education Inc.LGCY | 50.2/100Mixed-positive evidence75% evidence | BASING | 17.6/35 Revenue 28.3% · PAT 14.3% · OPM change -1.2 pp 83% evidence | 14.5/25 ROCE 6.8% · OPM 18.5% 76% evidence | 10.8/20 P/E 20.2× · PEG 1.26 65% evidence | 7.3/20 RS sector -9.7% · RS bench -5% · 1Y 9.8%0 of 12 weeks ahead 70% evidence |
| Exact sum: 17.6 + 14.5 + 10.8 + 7.3 = 50.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Laureate Education, Inc.LAUR | 49.6/100Thin evidence · provisional58% evidence | BREAKING OUT | 16.1/35 Revenue — · PAT — · OPM change -4.5 pp 45% evidence | 12.4/25 ROCE 12.7% · OPM -10.1% 76% evidence | 10.0/20 P/E 16.3× · PEG — 15% evidence | 11.1/20 RS sector -1.8% · RS bench 3.6% · 1Y 50.8%4 of 12 weeks ahead 100% evidence |
| Exact sum: 16.1 + 12.4 + 10 + 11.1 = 49.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Strategic Education, Inc.STRA | 47.2/100Thin evidence · provisional58% evidence | BASING | 18.1/35 Revenue — · PAT — · OPM change 0.3 pp 45% evidence | 11.8/25 ROCE 2.8% · OPM 13.4% 76% evidence | 10.9/20 P/E 12.8× · PEG — 15% evidence | 6.4/20 RS sector -11.4% · RS bench -6.6% · 1Y 8.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.1 + 11.8 + 10.9 + 6.4 = 47.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11New Oriental Education & Technology Group Inc.EDU | 47.1/100Thin evidence · provisional58% evidence | TURNING | 20.7/35 Revenue — · PAT — · OPM change 2.2 pp 45% evidence | 10.3/25 ROCE 1.8% · OPM 12.7% 76% evidence | 10.2/20 P/E 15.3× · PEG — 15% evidence | 5.9/20 RS sector -10.4% · RS bench -5.3% · 1Y 23.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.7 + 10.3 + 10.2 + 5.9 = 47.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Stride, Inc.LRN | 44.5/100Mixed-negative evidence81% evidence | ASLEEP | 13.0/35 Revenue 11% · PAT 3% · OPM change -0.8 pp 83% evidence | 14.8/25 ROCE 6.3% · OPM 20.5% 76% evidence | 13.5/20 P/E 13.6× · PEG 1.02 65% evidence | 3.2/20 RS sector -28.7% · RS bench -25.9% · 1Y -46.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 13 + 14.8 + 13.5 + 3.2 = 44.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 13Graham Holdings CompanyGHC | 44.0/100Thin evidence · provisional58% evidence | TURNING | 17.6/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence | 8.3/25 ROCE 1.3% · OPM 4.7% 76% evidence | 11.1/20 P/E 9.2× · PEG — 15% evidence | 7.0/20 RS sector -7.2% · RS bench -2.1% · 1Y 24.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.6 + 8.3 + 11.1 + 7 = 44 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14KinderCare Learning Companies, Inc.KLC | 42.5/100Thin evidence · provisional55% evidence | BREAKING OUT | 10.7/35 Revenue — · PAT — · OPM change -50.3 pp 45% evidence | 5.1/25 ROCE -8.7% · OPM -40.5% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 16.7/20 RS sector -0.2% · RS bench 4.4% · 1Y -43.6%9 of 12 weeks ahead 100% evidence |
| Exact sum: 10.7 + 5.1 + 10 + 16.7 = 42.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Covista Inc.CVSA | 40.4/100Mixed-negative evidence81% evidence | ASLEEP | 15.3/35 Revenue 9.7% · PAT 8.7% · OPM change -0.6 pp 83% evidence | 13.3/25 ROCE 4.1% · OPM 18.8% 76% evidence | 4.8/20 P/E 18× · PEG 2.93 65% evidence | 7.0/20 RS sector -5.6% · RS bench -1.1% · 1Y 6.6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 15.3 + 13.3 + 4.8 + 7 = 40.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Chegg, Inc.CHGG | 40.3/100Thin evidence · provisional58% evidence | 19.2/35 Revenue -43.4% · PAT — · OPM change 22.3 pp 62% evidence | 4.7/25 ROCE -0.5% · OPM -1.6% 76% evidence | 11.3/20 P/E 7.7× · PEG — 15% evidence | 5.1/20 RS sector -17.7% · RS bench -17.5% · 1Y -41.1%7 of 10 weeks ahead 70% evidence | |
| Exact sum: 19.2 + 4.7 + 11.3 + 5.1 = 40.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17McGraw Hill, Inc.this pageMH | 28.3/100Thin evidence · provisional58% evidence | BASING | 10.5/35 Revenue 0.1% · PAT — · OPM change -7.3 pp 62% evidence | 5.0/25 ROCE -0.1% · OPM -1.4% 76% evidence | 8.7/20 P/E 72.1× · PEG — 15% evidence | 4.1/20 RS sector -26.9% · RS bench -22.5% · 1Y -13.1%0 of 12 weeks ahead 70% evidence |
| Exact sum: 10.5 + 5 + 8.7 + 4.1 = 28.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Neucleus Group LimitedNEUC | 55.7/100Thin evidence · provisional11% evidence | 17.5/35 Revenue — · PAT — · OPM change — 0% evidence | 18.2/25 ROCE 156.9% · OPM — 46% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 17.5 + 18.2 + 10 + 10 = 55.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Phoenix Education Partners, Inc.PXED | 51.5/100Thin evidence · provisional36% evidence | ASLEEP | 13.5/35 Revenue — · PAT — · OPM change -5.7 pp 39% evidence | 17.4/25 ROCE 24.6% · OPM -40.1% 76% evidence | 10.6/20 P/E 14.1× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —1 of 12 weeks ahead 0% evidence |
| Exact sum: 13.5 + 17.4 + 10.6 + 10 = 51.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Coursera, Inc.COUR | 27.3/100Thin evidence · provisional49% evidence | TURNING | 11.0/35 Revenue — · PAT — · OPM change -4.9 pp 45% evidence | 3.3/25 ROCE -9.3% · OPM -12.9% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.0/20 RS sector -29.4% · RS bench -25.9% · 1Y -49.7%0 of 12 weeks ahead 70% evidence |
| Exact sum: 11 + 3.3 + 10 + 3 = 27.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is McGraw Hill, Inc.'s stock price today?
McGraw Hill, Inc. trades at $11.6, −24.5% over the past year. The company is valued at $2.0 B. The stock sits at 26% of its 52-week range of $9–$18, −12.6% versus its 200-day average. Against the S&P 500 it has been behind on a trailing-13-week view for 26 weeks. — as of 5 August 2026.
What were McGraw Hill, Inc.'s latest quarterly results?
McGraw Hill, Inc. reported revenue of $0.5 B and a net loss of $0.1 B for the Mar 26 quarter. Earnings per share were $−0.26. The operating margin was −2.2%, 8.6 pp lower than a year earlier. — as of 5 August 2026.
What is McGraw Hill, Inc.'s revenue?
McGraw Hill, Inc. reported revenue of $0.5 B in the Mar 26 quarter, −2.1% year on year. For the full FY26 fiscal year, revenue was $2.1 B (+0.0%). Over the last 4 years revenue compounded at 4.1% a year. — as of 5 August 2026.
What is McGraw Hill, Inc.'s profit?
McGraw Hill, Inc. earned $−0.1 B of net profit in the Mar 26 quarter. Full-year FY26 profit was $0.0 B. The operating margin ran −2.2% in the latest quarter. — as of 5 August 2026.
What is McGraw Hill, Inc.'s market cap?
McGraw Hill, Inc.'s market capitalisation is $2.0 B at a stock price of $11.6. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does McGraw Hill, Inc. pay a dividend?
No — McGraw Hill, Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
How is McGraw Hill, Inc. performing?
McGraw Hill, Inc.'s latest readings are below. Against the S&P 500 it has been behind on a trailing-13-week view for 26 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
Is McGraw Hill, Inc. beating the market?
Not lately — on a trailing-13-week view McGraw Hill, Inc. is currently behind the S&P 500 (26 weeks and counting; last ahead the week of 2026-02-06), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.0 years the stock moved −31% against the S&P 500's +21% — behind the index over the full window. — as of 5 August 2026.
Will McGraw Hill, Inc.'s stock price go up?
This page publishes no price forecast for McGraw Hill, Inc. What it measures instead: the stock price is $11.6. Direction is not something this site claims to know. — as of 5 August 2026.
Is the market betting against McGraw Hill, Inc.?
Somewhat — short interest is 8.5% of McGraw Hill, Inc.'s tradable float, about 1.8 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does McGraw Hill, Inc. have too much debt?
It carries real leverage — McGraw Hill, Inc.'s debt-to-equity is 3.66. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is McGraw Hill, Inc.'s capex?
McGraw Hill, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was $0.1 B. — as of 5 August 2026.
What is McGraw Hill, Inc.'s cash flow?
McGraw Hill, Inc. generated $0.3 B of operating cash flow in FY26 and $0.3 B of free cash flow after $0.1 B of capital spending. Reported profit that year was $0.0 B, so operating cash ran ahead of profit. — as of 5 August 2026.
How financially safe is McGraw Hill, Inc.?
On the balance sheet, the Z-score reads 0.54 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.
Where is McGraw Hill, Inc. in its business cycle?
McGraw Hill, Inc.'s FY26 operating margin was 13.3%, against a 5-year band of −19.6%–14.8%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran −2.2%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the McGraw Hill, Inc. story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is McGraw Hill, Inc. a stock worth studying right now?
This is not investment advice. The machine read: McGraw Hill, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.